使用68Ga标记的环状RGD九肽对癌症整合素αvβ6进行体内PET显像
研究基于TRAP和NODAGA螯合剂合成αvβ6整合素选择性肽环(FRGDLAFp(NMe)K)的单体、二聚体和三聚体偶联物并用68Ga标记,在H2009肿瘤异种移植的重度联合免疫缺陷小鼠中筛选。尽管多聚体亲和力更高(23-120 pM vs 单体260 pM),但TRAP基单体68Ga-avebehexin因高极性和额外负电荷促进肾清除而获得最佳显像结果。作者预计68Ga-avebehexin可用于αvβ6肿瘤和纤维化的PET显像。
要点
- 68Ga-avebehexin肿瘤摄取0.65%±0.04%ID/g,高于除肾脏外所有器官。
- 多聚体亲和力23-120 pM高于单体260 pM,但单体显像效果最佳。
- 免疫组化证实肿瘤、肺和胃有低但显著的靶点表达。
核心结论
- 由于PET对即使αvβ6整合素表达密度低的组织也高度敏感,作者预计68Ga-avebehexin可用于αvβ6肿瘤和纤维化的PET显像。
研究设计与样本
- 通过点击化学合成基于TRAP和NODAGA螯合剂的αvβ6整合素选择性肽环(FRGDLAFp(NMe)K)的单体、二聚体和三聚体偶联物,并用68Ga标记。
- 在携带H2009肿瘤(人肺腺癌)异种移植的重度联合免疫缺陷小鼠中进行PET和离体生物分布筛选。
- 用β6免疫组化测定肿瘤和其他组织中的αvβ6整合素表达。
主要发现
- 多聚体对αvβ6整合素的亲和力为23-120 pM,高于单体的260 pM。
- TRAP基单体68Ga-avebehexin因高极性(log D = -3.7)和螯合剂上额外负电荷(羧酸盐)促进肾清除而显示最有利的药代动力学。
- 68Ga-avebehexin肿瘤摄取为0.65%±0.04%ID/g,高于除肾脏外所有器官,从胃的最大值0.52±0.04%ID/g到胰腺几乎可忽略的0.07±0.01%ID/g。
- 免疫组化证实肿瘤、肺和胃中有低但显著的靶点表达。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Expression of the cellular transmembrane receptor αvβ6 integrin is essentially restricted to malignant epithelial cells in carcinomas of a broad variety of lineages, whereas it is virtually absent in normal adult tissues. Thus, it is a highly attractive target for tumor imaging and therapy. Furthermore, αvβ6 integrin plays an important role for the epithelial-mesenchymal interaction and the development of fibrosis. Methods: On the basis of the 68Ga chelators TRAP (triazacyclononane-triphosphinate) and NODAGA, we synthesized mono-, di-, and trimeric conjugates of the αvβ6 integrin-selective peptide cyclo(FRGDLAFp(NMe)K) via click chemistry. These were labeled with 68Ga and screened regarding their suitability for in vivo imaging of αvβ6 integrin expression by PET and ex vivo biodistribution in severe combined immunodeficiency mice bearing H2009 tumor (human lung adenocarcinoma) xenografts. For these, αvβ6 integrin expression in tumor and other tissues was determined by β6 immunohistochemistry. Results: Despite the multimers showing higher αvβ6 integrin affinities (23-120 pM) than the monomers (260 pM), the best results-that is, low background uptake and excellent tumor delineation-were obtained with the TRAP-based monomer 68Ga-avebehexin. This compound showed the most favorable pharmacokinetics because of its high polarity (log D = -3.7) and presence of additional negative charges (carboxylates) on the chelator, promoting renal clearance. Although tumor uptake was low (0.65% ± 0.04% injected dose per gram tissue [%ID/g]), it was still higher than in all other organs except the kidneys, ranging from a maximum for the stomach (0.52 ± 0.04 %ID/g) to almost negligible for the pancreas (0.07 ± 0.01 %ID/g). A low but significant target expression in tumor, lung, and stomach was confirmed by immunohistochemistry. Conclusion: Because of highly sensitive PET imaging even of tissues with low αvβ6 integrin expression density, we anticipate clinical applicability of 68Ga-avebehexin for imaging of αvβ6 tumors and fibrosis by PET.
引用
- Notni J, Reich D, Maltsev OV, et al. In Vivo PET Imaging of the Cancer Integrin αvβ6 Using 68Ga-Labeled Cyclic RGD Nonapeptides. J Nucl Med. 2016. PMID: 27980050. doi:10.2967/jnumed.116.182824
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。